Altimmune Inc risk profile
53 Elevated one input has moved against it
Measured 1 September 2026 from ALT's filed statements. Recomputed nightly.
53 (Elevated), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 78 | Stretched | Volatile | One-year price volatility — 69.1% |
| Operating pressure | 0 | Contained | Stable | Costs outgrowing revenue — -113.4 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.00x |
| Leverage and coverage | 35 | Normal | Stable | Interest cover — -53.19x |
| Competitive position | 69 | Stretched | Stable | Operating-margin gap against peers — -230,450.7 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.